Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Femoral Nerve Block in Elderly Hip Fracture
NCT03092466Unknown
- Sponsor
- ASST Gaetano Pini-CTO
- Start
- Feb 2017
- Primary completion
- Dec 2023
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in hip fracture (2 arms), sponsored by ASST Gaetano Pini-CTO. Primary endpoint: Incidence of postoperative delirium. Status: unknown.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT03092466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03092466.